Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Surgical Neurology

• Publication date

  2007-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.SURNEU.2006.10.050PMID 17537489
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Systematic immunohistochemical profiling of 378 brain tumors with 37 antibodies using tissue microarray technology

  2006cited by this paper
• [Correlation research between cancer stem cells and the pathological grades of neuroepithelial tumors].

  2006cited by this paper
• [Isolation and characterization of brain tumor stem cells in human medulloblastoma].

  2006cited by this paper
• Nestin as a diagnostic and prognostic marker: immunohistochemical analysis of its expression in different tumours

  2005cited by this paper
• Cathepsin L in glioma progression: comparison with cathepsin B.

  2005cited by this paper
• Nestin Is a Potential Mediator of Malignancy in Human Neuroblastoma Cells*

  2004cited by this paper
• Overexpression and localization of cathepsin B during the progression of human gliomas

  2004cited by this paper
• Comparison of Expression of Cathepsins B and L and MMP2 in Endothelial Cells and in Capillary Sprouting in Collagen Gel

  2004cited by this paper
• Inhibition of Tumorigenicity and Metastasis of Human Melanoma Cells by Anti-Cathepsin L Single Chain Variable Fragment

  2004cited by this paper
• Senescence-initiated Reversal of Drug Resistance

  2004cited by this paper
• Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma

  2004cited by this paper
• Identification of a cancer stem cell in human brain tumors.

  2003cited by this paper
• Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells.

  2003cited by this paper
• Proteases in brain tumour progression

  2003cited by this paper
• Applying the principles of stem-cell biology to cancer

  2003cited by this paper
• Imaging of Experimental Rat Gliomas Using a Clinical MR Scanner

  2003cited by this paper
• Lysosomal Enzymes, Cathepsins in Brain Tumour Invasion

  2002cited by this paper
• Musashi: a translational regulator of cell fate.

  2002cited by this paper
• Immunohistochemical Detection of Nestin in Pediatric Brain Tumors

  2002cited by this paper
• Nestin as a Marker for Proliferative Endothelium in Gliomas

  2002cited by this paper
• Musashi1, an evolutionarily conserved neural RNA-binding protein, is a versatile marker of human glioma cells in determining their cellular origin, malignancy, and proliferative activity.

  2001cited by this paper
• Expression of the neural RNA‐binding protein Musashi1 in human gliomas

  2001cited by this paper
• Clinical and Experimental Studies of Cysteine Cathepsins and Their Inhibitors in Human Brain Tumors

  2000cited by this paper
• Musashi1: An Evolutionally Conserved Marker for CNS Progenitor Cells Including Neural Stem Cells

  2000cited by this paper
• Notch signaling: cell fate control and signal integration in development.

  1999cited by this paper
• Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors.

  1999cited by this paper
• Notch Signaling : Cell Fate Control and Signal Integration in Development

  1999cited by this paper
• The inherent invasiveness of cerebral gliomas: implications for clinical management

  1999cited by this paper
• Cathepsin B and glioma invasion

  1999cited by this paper
• The new WHO classification of brain tumors.

  1999cited by this paper
• Site-specific experimental metastasis patterns of two human breast cancer cell lines in nude rats.

  1999cited by this paper
• Site‐specific experimental metastasis patterns of two human breast cancer cell lines in nude rats

  1999cited by this paper
• The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques.

  1998cited by this paper
• Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991.

  1998cited by this paper
• Mouse-Musashi-1, a neural RNA-binding protein highly enriched in the mammalian CNS stem cell.

  1996cited by this paper
• Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis.

  1995cited by this paper
• Synergism between growth-factors in the control of glioma cell-proliferation, migration and invasion in-vitro.

  1995cited by this paper
• Intermediate filaments: structure, dynamics, function, and disease.

  1994cited by this paper
• Expression of the neuroectodermal intermediate filament nestin in human melanomas.

  1994cited by this paper
• Cathepsin B expression and localization in glioma progression and invasion.

  1994cited by this paper
• The New WHO Classification of Brain Tumours

  1993cited by this paper
• Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells.

  1992cited by this paper
• Expression of the class VI intermediate filament nestin in human central nervous system tumors.

  1992cited by this paper
• Regulation of intermediate filament gene expression.

  1991cited by this paper
• CNS stem cells express a new class of intermediate filament protein.

  1990cited by this paper
• Multicellular tumor spheroids from human gliomas maintained in organ culture.

  1990cited by this paper
• Intermediate filament dynamics.

  1990cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Research Progress on Surface Markers of Glioma Cancer Stem Cells and Related Targeted Therapeutic Strategies

  2025cites this paper
• Temporal and regional expression changes and co‐staining patterns of metabolic and stemness‐related markers during glioblastoma progression

  2024cites this paper
• Unite and Conquer: Association of Two G-Quadruplex Aptamers Provides Antiproliferative and Antimigration Activity for Cells from High-Grade Glioma Patients

  2024cites this paper
• The hidden architects of glioblastoma multiforme: Glioma stem cells

  2024cites this paper
• Blastocyst-like Structures in the Peripheral Retina of Young Adult Beagles

  2024cites this paper
• CD97 maintains tumorigenicity of glioblastoma stem cells via mTORC2 signaling and is targeted by CAR Th9 cells

  2024cites this paper
• Musashi-1 Is a Novel Immunohistochemical Marker of Neuroendocrine Carcinoma of the Lung

  2023cites this paper
• Characterization of Switch/Sucrose Nonfermenting Complex Proteins and Nestin Expression in a Cohort of Pediatric Central Nervous System Tumors

  2023cites this paper
• Nanomedicines Targeting Glioma Stem Cells.

  2022cites this paper
• Inter and intra-tumor heterogeneity of paediatric type diffuse high-grade gliomas revealed by single-cell mass cytometry

  2022cites this paper
• [Advances in research of Musashi2 in solid tumors].

  2022cites this paper
• PNJ scaffolds promote microenvironmental regulation of glioblastoma stem-like cell enrichment and radioresistance.

  2022cites this paper
• Study of Cancer Stem Cell Subpopulations in Breast Cancer Models

  2022cites this paper
• Diagnostic Value of Nestin Expression in Adult Gliomas

  2022cites this paper
• Nestin Expression as a Diagnostic and Prognostic Marker in Colorectal Cancer and Other Tumors

  2021cites this paper
• Optogenetic stimulation of entorhinal cortex reveals the implication of insulin signaling in adult rat's hippocampal neurogenesis.

  2021cites this paper
• Histopathological investigation of the 1p/19q-codeleted gliomas resected following alkylating agent chemotherapy

  2021cites this paper
• Characterization of a new human astrocytoma cell line SHG140: cell proliferation, cell phenotype, karyotype, STR markers and tumorigenicity analysis

  2021cites this paper
• Evolution of Experimental Models in the Study of Glioblastoma: Toward Finding Efficient Treatments

  2021cites this paper
• Differences in stem cell marker and osteopontin expression in primary and recurrent glioblastoma

  2021cites this paper
• GDF15 promotes glioma stem cell-like phenotype via regulation of ERK1/2–c-Fos–LIF signaling

  2021cites this paper
• The Strange Case of Jekyll and Hyde: Parallels Between Neural Stem Cells and Glioblastoma-Initiating Cells

  2021cites this paper
• Transitioning pre-clinical glioblastoma models to clinical settings with biomarkers identified in 3D cell-based models: A systematic scoping review.

  2021cites this paper
• Clinicopathological Significance of Nestin Expression as a Diagnostic and Prognostic Marker in Brain Gliomas, Independent of IDH Mutation

  2021cites this paper
• PIM1 Inhibition Affects Glioblastoma Stem Cell Behavior and Kills Glioblastoma Stem-like Cells

  2021cites this paper
• Differential expression of stem cell markers in proliferating cells in glioma

  2021cites this paper
• Preclinical Toxicology of rQNestin34.5v.2: An Oncolytic Herpes Virus with Transcriptional Regulation of the ICP34.5 Neurovirulence Gene

  2020cites this paper
• Regulating Stem Cell-Related Genes Induces the Plastic Differentiation of Cancer Stem Cells to Treat Breast Cancer

  2020cites this paper
• OSlgg: An Online Prognostic Biomarker Analysis Tool for Low-Grade Glioma

  2020cites this paper
• Establishment and Characterization of Four Long-Term Cultures of Neural Stem/Progenitor Cell Lines from the Japanese Flounder Paralichthys olivaceus

  2020cites this paper
• Understanding Glioblastoma Biomarkers: Knocking a Mountain with a Hammer

  2020cites this paper
• Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma

  2020cites this paper
• Expression of markers of neural stem and progenitor cells in glioblastoma multiforme in relation to tumor recurrence and overall survival

  2020cites this paper
• Efficient generation of neural-like cells from porcine ovarian putative stem cells - morphological characterization and evaluation of their electrophysiological properties.

  2020cites this paper
• The Cytoskeleton—A Complex Interacting Meshwork

  2019cites this paper
• Clinical significance of CD133 and Nestin in astrocytic tumor: The correlation with pathological grade and survival

  2019cites this paper
• The Role of SVZ Stem Cells in Glioblastoma

  2019cites this paper
• Biomarkers of Cancer Stem Cells in Glioblastoma Multiforme and Histological Picture of Cancer

  2019cites this paper
• Effect of Angelica polysaccharide on brain senescence of Nestin‐GFP mice induced by D‐galactose

  2019cites this paper
• Immunohistochemical Expression of Nestin as Cancer Stem Cell marker in Gliomas

  2019cites this paper
• Heterogenic expression of stem cell markers in patient-derived glioblastoma spheroid cultures exposed to long-term hypoxia

  2018cites this paper
• Neural stem cell‐derived factors inhibit the growth and invasion of U87 stem‐like cells in vitro

  2018cites this paper
• Paclitaxel Loaded Magnetic Nanoparticles Induce In vivo Tumor Growth Inhibition in a Rat Glioblastoma Model

  2018cites this paper
• gioblastoma topography and stem cell markers related with survival

  2018cites this paper
• Etoposide loaded layered double hydroxide nanoparticles reversing chemoresistance and eradicating human glioma stem cells in vitro and in vivo.

  2018cites this paper
• Pancreatic tumor microenvironment confers highly malignant properties on pancreatic cancer cells

  2018cites this paper
• Modeling Microenvironmental Regulation of Glioblastoma Stem Cells: A Biomaterials Perspective

  2018cites this paper
• Mammalian target of rapamycin inhibitors, temsirolimus and torin 1, attenuate stemness-associated properties and expression of mesenchymal markers promoted by phorbol-myristate-acetate and oncostatin-M in glioblastoma cells

  2017cites this paper
• Mechanisms regulating radiosensitivity of glioma stem cells.

  2017cites this paper
• Endothelium-induced three-dimensional invasion of heterogeneous glioma initiating cells in a microfluidic coculture platform.

  2017cites this paper
• Stemness-related markers in cancer

  2017cites this paper
• Nestin, an important marker for differentiating oligodendroglioma from astrocytic tumors

  2017influential citation
• Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness

  2017cites this paper
• Hypothalamic stem cells control aging speed partly through exosomal miRNAs

  2017cites this paper
• Glioma Stem-Like Cells in Tumor Growth and Therapy Resistance of Glioblastoma

  2017cites this paper
• Brain Cancer Stem Cells: The Emerging Role of Chromatin in Glioma Biology

  2017cites this paper
• The transcription factor Olig2 is important for the biology of diffuse intrinsic pontine gliomas

  2017cites this paper
• Advances in Biology and Treatment of Glioblastoma

  2017cites this paper
• Is serum level of nestin useful in detecting epithelial ovarian cancer?

  2017cites this paper
• Netrins in glioma biology: regulators of tumor cell proliferation, motility and stemness

  2017cites this paper
• Resistance of Glioblastomas to Radiation Therapy

  2016cites this paper
• Glioma Stem Cells

  2016cites this paper
• Tumor Microenvironment, Hypoxia, and Stem Cell-Related Radiation Resistance

  2016cites this paper
• Expression and clinical significance of nestin in astrocytic tumors.

  2016cites this paper
• Design, synthesis and biological evaluation of small molecules for controlling cellular development

  2016cites this paper
• Characterization of CAMTA1 and Nkx2.2 in the context of glioblastoma cancer stem cell biology

  2016cites this paper
• Nestin Expression Is Associated with Poor Clinicopathological Features and Prognosis in Glioma Patients: an Association Study and Meta-analysis

  2016cites this paper
• Mechanisms of tumor cell resistance to the current targeted-therapy agents

  2016cites this paper
• High expression of VEGF and PI3K in glioma stem cells provides new criteria for the grading of gliomas.

  2016cites this paper
• Glioma Cells in the Tumor Periphery Have a Stem Cell Phenotype

  2016cites this paper
• Immunohistochemical Study of Prognostic Relevance of Nestin and Survivin Expression in Astrocytic glioma

  2016influential citation
• Effect of bexarotene on differentiation of glioblastoma multiforme compared with ATRA

  2016cites this paper
• Prognostic value of Musashi-1 in endometrioid adenocarcinoma.

  2015cites this paper
• Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells

  2015cites this paper
• Effect of itraconazole on mouse mesencephalic neurons

  2015cites this paper
• Mechanobiological Regulation of Glioblastoma Initiation and Invasion

  2015cites this paper
• Immunohistochemical analysis of GFAP-δ and nestin in cerebral astrocytomas

  2015cites this paper
• Exposure to acoustic stimuli promotes the development and differentiation of neural stem cells from the cochlear nuclei through the clusterin pathway

  2015cites this paper
• Original Article Hyperbaric oxygenation promotes neural stem cell proliferation and protects the learning and memory ability in neonatal hypoxic-ischemic brain damage

  2015cites this paper
• Immunohistochemical expression of nestin in rhabdomyosarcoma: implications for clinicopathology and patient outcome.

  2015cites this paper
• Roles and potential clinical applications of intermediate filament proteins in brain tumors.

  2015cites this paper
• Nestin expression as an independent indicator of poor prognosis for patients with anaplastic thyroid cancer.

  2015cites this paper
• Growth Factor Mediated Reprogramming of Adult Corneal Keratocytes as an Exemplar of In Vivo Tissue Engineering

  2015cites this paper
• Immunophenotypic Characterization of Human Glioblastoma Stem Cells: Correlation With Clinical Outcome

  2015cites this paper
• RNA-Binding Protein Musashi1 Is a Central Regulator of Adhesion Pathways in Glioblastoma

  2015cites this paper
• Isolation and characterization of stem cells from human central nervous system malignancies.

  2015cites this paper
• Malignant clinical features of anaplastic gliomas without IDH mutation.

  2015cites this paper
• Improving treatment of glioblastoma : new insights in targeting cancer stem cells effectively

  2015cites this paper
• Role of nestin in glioma invasion

  2015cites this paper
• Hyperbaric oxygenation promotes neural stem cell proliferation and protects the learning and memory ability in neonatal hypoxic-ischemic brain damage.

  2015influential citation
• Prognostic value of erythrocyte sedimentation rate and C-reactive protein in the blood of patients with glioma.

  2014cites this paper
• Clinicopathological significance of expression of nestin, a neural stem/progenitor cell marker, in human glioma tissue

  2014cites this paper
• Stem cell markers nestin and CD133 are markers of aggressive behavior in astrocytic tumors: an immunohistochemical study in an Egyptian population

  2014influential citation
• Stem cells and gliomas: past, present, and future

  2014cites this paper
• Contribution of nestin positive esophageal squamous cancer cells on malignant proliferation, apoptosis, and poor prognosis

  2014cites this paper
• Nestin positively regulates the Wnt/β-catenin pathway and the proliferation, survival and invasiveness of breast cancer stem cells

  2014cites this paper
• Original Article Clinical value of CD133 and nestin in patients with glioma: a population-based study

  2014cites this paper
• The impact of arsenic trioxide and all-trans retinoic acid on p53 R273H-codon mutant glioblastoma

  2014cites this paper
• Indatraline inhibits Rho- and calcium-mediated glioblastoma cell motility and angiogenesis.

  2014cites this paper
• High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II–III astrocytomas and oligoastrocytomas

  2014cites this paper